RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway
Feifei Sun, Xinpei Wang, Jing Hu, Junmei Liu, Xin Wang, Wenqiao Jia, Zeyuan Yu, Lin Gao, Baokai Dou, Ru Zhao, Tingting Feng, Xueli Wang, Wenbo Zhang, Hui Liu, Kaihua Liu, Yang Shao, Xuesen Dong, Bo Han
Topics & Concepts
EnzalutamideCancer researchBiologyProstate cancerCell growthDownregulation and upregulationMAPK/ERK pathwaySignal transductionCancerAndrogen receptorCell biologyGeneticsGeneProstate Cancer Treatment and ResearchUbiquitin and proteasome pathwaysHippo pathway signaling and YAP/TAZ